|
|
Volumn 2, Issue 3, 2003, Pages 175-176
|
|
The painful reality. Market indicators
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIHISTAMINIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBAMAZEPINE;
CELECOXIB;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
ETIRACETAM;
GABAPENTIN;
LAMOTRIGINE;
LICOFELONE;
LIPOXYGENASE INHIBITOR;
LUMIRACOXIB;
MORPHINE 6 GLUCURONIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OPIATE;
PHENYTOIN;
PIZOTIFEN;
PREGABALIN;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ROFECOXIB;
SEROTONIN 1 AGONIST;
SEROTONIN ANTAGONIST;
SUMATRIPTAN SUCCINATE;
TOPIRAMATE;
TRAMADOL;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNINDEXED DRUG;
VALPROIC ACID;
NARCOTIC AGENT;
ANALGESIC ACTIVITY;
ANTIINFLAMMATORY ACTIVITY;
ARTHRALGIA;
BONE PAIN;
CANCER PAIN;
DISEASE SEVERITY;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MARKETING;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SELECTIVITY;
DYSMENORRHEA;
HUMAN;
INFLAMMATION;
MEDICAL SPECIALIST;
MIGRAINE;
MYALGIA;
NEUROPATHIC PAIN;
NOTE;
PAIN;
PRESCRIPTION;
PRIORITY JOURNAL;
SIDE EFFECT;
PERIPHERAL NEUROPATHY;
REVIEW;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
HUMANS;
INFLAMMATION;
MIGRAINE DISORDERS;
NARCOTICS;
PAIN;
PERIPHERAL NERVOUS SYSTEM DISEASES;
|
|
EID: 0037364066
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd1038 Document Type: Note |
|
Times cited : (31)
|
|
References (2)
|
